Towards Healthcare
Middle East and Africa Life Science Market
Updated Date: 10 October 2025   |   Report Code: 6288
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Middle East and Africa Life Science Market Industry Shift

Projections indicate that, Middle East and Africa life science industry is projected to rise from USD 4.47 billion in 2024 to USD 13.07 billion by 2034, reflecting a CAGR of 11.32% over the next decade. The market is expanding due to rising R&D investments, technological advancements, and growing demand for precision medicine. In the Middle East and Africa, growth is led by strong government healthcare investments, expanding biopharma manufacturing, and GCC dominance as an innovation hub.

Last Updated : 10 October 2025 Category: Life Sciences Insight Code: 6288 Format: PDF / PPT / Excel

Content

TOC is not Available for this Report

FAQ's

Answer : The Middle East and Africa life science market holds a valuation of USD 5.04 billion as of 2025, and will expand to USD 13.07 billion by 2034, achieving a CAGR of 11.32% between 2024 and 2034.

Answer : GCC countries are currently leading the Middle East and Africa Life Science market due to a focus on healthcare modernization, digital health adoption, and strategic public-private partnerships boosted sector growth.

Answer : PerkinElmer (Revvity), Lonza Group, Sartorius AG, Charles River Laboratories, Eurofins Scientific 
Any Questions

Meet the Team

Rohan Patil is a seasoned market research professional with over 5+ years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

Learn more about Rohan Patil

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar